{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:47:53Z","timestamp":1792043273929,"version":"4.4.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"DOI":"10.1007\/s10787-026-02417-w","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:02Z","timestamp":1792000982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic approaches to Alzheimer\u2019s disease: exploring the combined efficacy of phytoconstituents and conventional drugs"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2993-5348","authenticated-orcid":false,"given":"Abhishek","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2417_CR1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","volume":"14","author":"H Abbas","year":"2022","unstructured":"Abbas H, El Sayed NS, Youssef NAHA, Gaafar PME, Mousa MR, Fayez AM, Elsheikh MA (2022) Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: Focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. J Pharmaceutics 14:1003","journal-title":"J Pharmaceutics"},{"key":"2417_CR2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13195-022-01055-y","volume":"14","author":"C Abdelnour","year":"2022","unstructured":"Abdelnour C, Agosta F, Bozzali M, Foug\u00e8re B, Iwata A, Nilforooshan R, Takada LT, Vi\u00f1uela F, Traber M (2022) Perspectives and challenges in patient stratification in Alzheimer\u2019s disease. J Alzheimer\u2019s Res Therapy 14:112","journal-title":"J Alzheimer's Res Therapy"},{"key":"2417_CR3","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1007\/s12011-021-03073-7","volume":"200","author":"OAR Abozaid","year":"2022","unstructured":"Abozaid OAR, Sallam MW, El-Sonbaty S, Aziza S, Emad B, Ahmed ESA (2022) Resveratrol-selenium nanoparticles alleviate neuroinflammation and neurotoxicity in a rat model of Alzheimer\u2019s disease by regulating Sirt1\/miRNA-134\/GSK3\u03b2 expression. J Biol Trace Element Res 200:5104\u20135114","journal-title":"J Biol Trace Element Res"},{"key":"2417_CR169","doi-asserted-by":"crossref","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB, Sanusi KO, Ugusman A, Mohamed W, Kamal H, Ibrahim NH, Khoo CS, Kumar J (2022) Alzheimer\u2019s disease: an update and insights into pathophysiology. J Front Aging Neurosci 14:742408","journal-title":"J Front Aging Neurosci"},{"key":"2417_CR5","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.3390\/ijms22179583","volume":"22","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, Jo MH, Ikram M, Khan A, Kim MO (2021) Deciphering the potential neuroprotective effects of luteolin against A\u03b21\u201342-Induced alzheimer\u2019s disease. J Int J Molecular Sci 22:9583","journal-title":"J Int J Molecular Sci"},{"key":"2417_CR6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12640-017-9701-5","volume":"31","author":"AJ Akinyemi","year":"2017","unstructured":"Akinyemi AJ, Oboh G, Oyeleye SI, Ogunsuyi O (2017) Anti-amnestic effect of curcumin in combination with donepezil, an anticholinesterase drug: involvement of cholinergic system. J Neurotoxicity Res 31:560\u2013569","journal-title":"J Neurotoxicity Res"},{"key":"2417_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/1871527318666190319141835","volume":"18","author":"F Ali","year":"2019","unstructured":"Ali F, Siddique YH (2019) Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer\u2019s disease. J CNS Neurol Disorders-Drug Targets-CNS Neurol Disorders 18:352\u2013365","journal-title":"J CNS Neurol Disorders-Drug Targets-CNS Neurol Disorders"},{"key":"2417_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/brainsci15020215","volume":"15","author":"MN ALNasser","year":"2025","unstructured":"ALNasser MN, Alboraiy GM, Alsowig EM, Alqattan FM (2025) Cholinesterase inhibitors from plants and their potential in Alzheimer\u2019s treatment: Systematic review. J Brain Sci 15:215","journal-title":"J Brain Sci"},{"key":"2417_CR170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/nano14020199","volume":"14","author":"N Al-Saran","year":"2024","unstructured":"Al-Saran N, Subash-Babu P, Al-Harbi LN, Alrfaei BM, Alshatwi AA (2024) Neuroprotective effect of solid lipid nanoparticles loaded with lepidium sativum (l.) seed bioactive components enhance bioavailability and Wnt\/\u0392-Catenin\/Camk-Ii Signaling Cascade In Sh-Sy5y neuroblastoma cells. J Nanomaterials 14:199","journal-title":"J Nanomaterials"},{"key":"2417_CR10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112342","volume":"14","author":"I \u00c1lvarez-Berbel","year":"2022","unstructured":"\u00c1lvarez-Berbel I, Espargar\u00f3 A, Viayna A, Caballero AB, Busquets MA, G\u00e1mez P, Luque FJ, Sabat\u00e9 R (2022) Three to tango: inhibitory effect of quercetin and apigenin on acetylcholinesterase, amyloid-\u03b2 aggregation and acetylcholinesterase-amyloid interaction. Pharmaceutics 14:2342","journal-title":"Pharmaceutics"},{"key":"2417_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","volume":"36","author":"P Anand","year":"2013","unstructured":"Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer\u2019s disease. J Arch Pharm Res 36:375\u2013399","journal-title":"J Arch Pharm Res"},{"key":"2417_CR12","first-page":"116","volume":"6","author":"TJ Anastasio","year":"2015","unstructured":"Anastasio TJ (2015) Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease. J Front Pharmacol 6:116","journal-title":"J Front Pharmacol"},{"key":"2417_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/WAD.0b013e31816653bc","volume":"22","author":"A Atri","year":"2008","unstructured":"Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008) Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 22:209\u2013221","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2417_CR14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jpp\/rgaf020","volume":"77","author":"AS Awad","year":"2025","unstructured":"Awad AS, El-Mokadem BM, Sherif MM, Bishr A (2025) Can Quercetin protect against the pre-disposing factors for Alzheimer\u2019s disease via inhibiting NLRP3 inflammasome pathway? J Pharm Pharmacol 77:911\u2013921","journal-title":"J Pharm Pharmacol"},{"key":"2417_CR15","volume":"12","author":"S Aye","year":"2025","unstructured":"Aye S, Johansson G, Hock C, Lannfelt L, Sims JR, Blennow K, Frederiksen KS, Graff C, Molinuevo JL, Scheltens P (2025) Point of view: Challenges in implementation of new immunotherapies for Alzheimer\u2019s disease. J Prevent Alzheimer\u2019s Disease 12:100022","journal-title":"J Prevent Alzheimer's Disease"},{"key":"2417_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12986-024-00792-1","volume":"21","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A, Abutalebian F (2024) Unraveling the therapeutic efficacy of resveratrol in Alzheimer\u2019s disease: An umbrella review of systematic evidence. J Nutrition Metabol 21:15","journal-title":"J Nutrition Metabol"},{"key":"2417_CR17","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1002\/ptr.8200","volume":"38","author":"E Azzini","year":"2024","unstructured":"Azzini E, Pe\u00f1a-Corona SI, Hern\u00e1ndez-Parra H, Chandran D, Saleena LAK, Sawikr Y, Peluso I, Dhumal S, Kumar M, Leyva-G\u00f3mez G (2024) Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer\u2019s disease: targeting neuroinflammation strategies. J Phytotherapy Res 38:3169\u20133189","journal-title":"J Phytotherapy Res"},{"key":"2417_CR18","volume":"222","author":"L Bai","year":"2021","unstructured":"Bai L, Liu R, Wang R, Xin Y, Zuntao W, Ba Y, Zhang H, Cheng X, Zhou G, Huang H (2021) Attenuation of Pb-induced A\u03b2 generation and autophagic dysfunction via activation of SIRT1: Neuroprotective properties of resveratrol. J Ecotoxicol Environ Safety 222:112511","journal-title":"J Ecotoxicol Environ Safety"},{"key":"2417_CR19","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.3390\/molecules27249043","volume":"27","author":"S Bakrim","year":"2022","unstructured":"Bakrim S, Aboulaghras S, El Menyiy N, El Omari N, Assaggaf H, Lee L-H, Montesano D, Gallo M, Zengin G, AlDhaheri Y (2022) Phytochemical compounds and nanoparticles as phytochemical delivery systems for Alzheimer\u2019s disease management. J Molecules 27:9043","journal-title":"J Molecules"},{"key":"2417_CR20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","volume":"13","author":"RJ Bateman","year":"2017","unstructured":"Bateman RJ, Benzinger TL, Berry S, Clifford DB, Duggan C, Fagan AM, Fanning K, Farlow MR, Hassenstab J, McDade ME (2017) The DIAN-TU Next Generation Alzheimer\u2019s prevention trial: adaptive design and disease progression model. J Alzheimer\u2019s Dementia 13:8\u201319","journal-title":"J Alzheimer's Dementia"},{"key":"2417_CR21","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, Such GK (2024) Polymeric nanoparticles for drug delivery. J Chem Rev 124:5505\u20135616","journal-title":"J Chem Rev"},{"key":"2417_CR22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/ptr.8435","volume":"39","author":"RS Bhattacharya","year":"2025","unstructured":"Bhattacharya RS, Singh R, Panghal A, Thakur A, Singh L, Verma RK, Singh C, Goyal M, Kumar J (2025) Multi-targeting phytochemicals for Alzheimer\u2019s disease. J Phytotherapy Res 39:1453\u20131483","journal-title":"J Phytotherapy Res"},{"key":"2417_CR23","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2174\/1568026616666160204121431","volume":"16","author":"N Braidy","year":"2016","unstructured":"Braidy N, Jugder B-E, Poljak A, Jayasena T, Mansour H, Nabavi SM, Sachdev P, Grant R (2016) Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer\u2019s disease. Curr Top Med Chem 16:1951\u20131960","journal-title":"Curr Top Med Chem"},{"key":"2417_CR24","volume":"2014","author":"N Brondino","year":"2014","unstructured":"Brondino N, Re S, Boldrini A, Cuccomarino A, Lanati N, Barale F, Politi P (2014) Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. J Sci World Journal 2014:174282","journal-title":"J Sci World Journal"},{"key":"2417_CR25","doi-asserted-by":"crossref","unstructured":"Cai Z, Wang C, Yang W (2016). Role of berberine in Alzheimer\u2019s disease. J Neuropsychiatric Disease Treatment 2509\u201320.","DOI":"10.2147\/NDT.S114846"},{"key":"2417_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11101-017-9490-8","volume":"16","author":"Y Cao","year":"2017","unstructured":"Cao Y, Xie Y, Liu L, Xiao A, Li Y, Zhang C, Fang X, Zhou Y (2017) Influence of phytochemicals on the biocompatibility of inorganic nanoparticles: a state-of-the-art review. J Phytochem Rev 16:555\u2013563","journal-title":"J Phytochem Rev"},{"key":"2417_CR27","doi-asserted-by":"publisher","unstructured":"Caporaso R (2017) Design and synthesis of new chemical entities to exploring the multifactorial nature of Alzheimer's disease. https:\/\/doi.org\/10.6092\/unibo\/amsdottorato\/8141","DOI":"10.6092\/unibo\/amsdottorato\/8141"},{"key":"2417_CR28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","volume":"15","author":"KK Cheng","year":"2013","unstructured":"Cheng KK, Yeung CF, Ho SW, Chow SF, Chow AHL, Baum L (2013) Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. J AAPS J 15:324\u2013336","journal-title":"J AAPS J"},{"key":"2417_CR29","doi-asserted-by":"crossref","first-page":"5698119","DOI":"10.1155\/2024\/5698119","volume":"2024","author":"M Cheng","year":"2024","unstructured":"Cheng M, Yuan C, Yetao J, Liu Y, Shi B, Yang Y, Jin S, He X, Zhang L, Min D (2024) Quercetin attenuates oxidative stress and apoptosis in brain tissue of APP\/PS1 double transgenic AD mice by regulating Keap1\/Nrf2\/HO-1 pathway to improve cognitive impairment. J Behavioural Neurol 2024:5698119","journal-title":"J Behavioural Neurol"},{"key":"2417_CR30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.9758\/cpn.2021.19.3.423","volume":"19","author":"T-I Chiang","year":"2021","unstructured":"Chiang T-I, Yi-Hsiang Y, Lin C-H, Lane H-Y (2021) Novel biomarkers of Alzheimer\u2019s disease: based upon N-methyl-D-aspartate receptor hypoactivation and oxidative stress. J Clinical Psychopharmacol Neurosci 19:423","journal-title":"J Clinical Psychopharmacol Neurosci"},{"key":"2417_CR31","doi-asserted-by":"crossref","DOI":"10.3390\/nu17010078","volume":"17","author":"N Cichon","year":"2024","unstructured":"Cichon N, Grabowska W, Gorniak L, Stela M, Harmata P, Ceremuga M, Bijak M (2024) Mechanistic and therapeutic insights into flavonoid-based inhibition of acetylcholinesterase: implications for neurodegenerative diseases. Nutrients 17:78","journal-title":"Nutrients"},{"key":"2417_CR32","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"M Compagnoni","year":"2020","unstructured":"Compagnoni M, Giacomo AD, Fonzo SC, Comi GP, Bresolin N, Masliah E (2020) The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. J Molecular Neurobiol 57:2959\u20132980","journal-title":"J Molecular Neurobiol"},{"key":"2417_CR33","doi-asserted-by":"crossref","unstructured":"Cummings JL, Burstein AH, Fillit H (2025) Alzheimer combination therapies: overview and scenarios, J Prevent Alzheimer's Dis 100328.","DOI":"10.1016\/j.tjpad.2025.100328"},{"key":"2417_CR34","doi-asserted-by":"crossref","first-page":"1287750","DOI":"10.3389\/fphar.2023.1287750","volume":"14","author":"L Dan","year":"2024","unstructured":"Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H, Qiao L, Xie P (2024) Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer\u2019s disease: a systematic review and meta-analysis. J Front Pharmacol 14:1287750","journal-title":"J Front Pharmacol"},{"key":"2417_CR35","volume":"4","author":"AV Deepa","year":"2025","unstructured":"Deepa AV (2025) Plant extracts and phytochemicals targeting Alzheimer\u2019s through acetylcholinesterase inhibition. J Exploration Neurosci 4:100697","journal-title":"J Exploration Neurosci"},{"key":"2417_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neurol.2022.09.003","volume":"179","author":"C Delaby","year":"2023","unstructured":"Delaby C, Hirtz C, Lehmann S (2023) Overview of the blood biomarkers in Alzheimer\u2019s disease: Promises and challenges. J Revue Neurologique 179:161\u2013172","journal-title":"J Revue Neurologique"},{"key":"2417_CR37","doi-asserted-by":"crossref","first-page":"1669405","DOI":"10.3389\/fnagi.2025.1669405","volume":"17","author":"Y Deng","year":"2025","unstructured":"Deng Y, Yin H, Zihao L, Lan H, Liu W, Zuo C, Pan N, Tian X, Gong Q (2025) LRP1 at the crossroads of A\u03b2 clearance and therapeutic targeting in Alzheimer\u2019s disease. J Front Aging Neurosci 17:1669405","journal-title":"J Front Aging Neurosci"},{"key":"2417_CR38","volume":"8","author":"NV Dokholyan","year":"2022","unstructured":"Dokholyan NV, Mohs RC, Bateman RJ (2022) Challenges and progress in research, diagnostics, and therapeutics in Alzheimer\u2019s disease and related dementias. J Alzheimer\u2019s Dementia: Transl Res Clinical Interven 8:e12330","journal-title":"J Alzheimer's Dementia: Transl Res Clinical Interven"},{"key":"2417_CR39","doi-asserted-by":"crossref","first-page":"41539","DOI":"10.1038\/srep41539","volume":"7","author":"TP Domiciano","year":"2017","unstructured":"Domiciano TP, Wakita D, Jones HD, Crother TR, Verri Jr WA, Arditi M, Shimada K (2017) Quercetin inhibits inflammasome activation by interfering with ASC oligomerization and prevents interleukin-1 mediated mouse vasculitis. J Sci. Rep. 7:41539","journal-title":"J Sci. Rep."},{"key":"2417_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fnagi.2020.00119","volume":"12","author":"NS Dourado","year":"2020","unstructured":"Dourado NS, dos Santos C, Souza MM, De Almeida A, Bispo A, da Silva B, Dos Santos L, Silva VDA, Assis AMD, Souza J, da Silva D, Souza O, de Fatima M, Costa D (2020) Neuroimmunomodulatory and neuroprotective effects of the flavonoid apigenin in in vitro models of neuroinflammation associated with Alzheimer\u2019s disease. J Front Aging Neurosci. 12:119","journal-title":"J Front Aging Neurosci."},{"key":"2417_CR41","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.3390\/ma14123332","volume":"14","author":"D Ege","year":"2021","unstructured":"Ege D (2021) Action mechanisms of curcumin in Alzheimer\u2019s disease and its brain targeted delivery. J Mater 14:3332","journal-title":"J Mater"},{"key":"2417_CR42","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/pca.70020","volume":"36","author":"T Ehtezazi","year":"2025","unstructured":"Ehtezazi T, Sarker SD (2025) Phytochemical nanoparticles for the treatment of neurological disorders. J Phytochem Anal 36:1918\u20131935","journal-title":"J Phytochem Anal"},{"key":"2417_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119964","volume":"285","author":"AM Elfiky","year":"2021","unstructured":"Elfiky AM, Mahmoud AA, Elreedy HA, Ibrahim KS, Ghazy MA (2021) Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer\u2019s disease rat model. J Life Sci 285:119964","journal-title":"J Life Sci"},{"key":"2417_CR44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2217\/nnm-2017-0220","volume":"13","author":"YSR Elnaggar","year":"2018","unstructured":"Elnaggar YSR, Elsheikh MA, Abdallah OY (2018) Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics. Nanomedicine (Lond) 13:209\u2013232","journal-title":"Nanomedicine (Lond)"},{"key":"2417_CR45","doi-asserted-by":"crossref","first-page":"e2024VR01","DOI":"10.1590\/1980-5764-dn-2024-vr01","volume":"18","author":"E Engelhardt","year":"2024","unstructured":"Engelhardt E, Resende EPF, Gomes KB (2024) Physiopathological mechanisms underlying Alzheimer\u2019s disease: A narrative review. J Dementia Neuropsychol 18:e2024VR01","journal-title":"J Dementia Neuropsychol"},{"key":"2417_CR46","doi-asserted-by":"crossref","unstructured":"Eshwaraiah, PKS, Bairy KL, Kiran A, Konuri A, Nayak V (2025) Neuropharmacological insights into artesunate alone and rivastigmine co-therapy: Synergistic modulation of cognitive impairment in Alzheimer\u2019s disease. J Eur J Pharmacol 178470.","DOI":"10.1016\/j.ejphar.2025.178470"},{"key":"2417_CR47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s12035-013-8401-2","volume":"47","author":"RL Frozza","year":"2013","unstructured":"Frozza RL, Bernardi A, Hoppe JB, Meneghetti AB, Matt\u00e9 A, Battastini AMO, Pohlmann AR, Guterres SS, Salbego C (2013) Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules. J Molecular Neurobiol 47:1066\u20131080","journal-title":"J Molecular Neurobiol"},{"key":"2417_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.37349\/ei.2022.00048","volume":"2","author":"X Gao","year":"2022","unstructured":"Gao X, Zhang X, Sun Y, Dai X (2022) Mechanism of NLRP3 inflammasome activation and its role in Alzheimers disease. J Exploration Immunol 2:229\u2013244","journal-title":"J Exploration Immunol"},{"key":"2417_CR49","doi-asserted-by":"crossref","unstructured":"Ghosh S, Solanki R, Bhatia D, Sankaranarayanan S (2025) Nanomaterials for delivery of medicinal plant extracts and phytochemicals: Potential applications and future perspectives, J Plant Nano Biology 100161.","DOI":"10.1016\/j.plana.2025.100161"},{"key":"2417_CR50","volume":"10","author":"J Godos","year":"2021","unstructured":"Godos J, Grosso G (2021) Dietary antioxidants and brain health: focus on cognitive and affective disorders. Antioxidants (Basel) 10:1659","journal-title":"Antioxidants (Basel)"},{"key":"2417_CR51","doi-asserted-by":"crossref","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BA Gomes","year":"2018","unstructured":"Gomes BA, Quadros JP, Silva B, Romeiro CFR, Santos SMD, Rodrigues CA, Gon\u00e7alves PR, Sakai JT, Mendes PFS, Varela ELP, Monteiro MC (2018) Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. J Oxidative Med Cellular Longevity 2018:8152373","journal-title":"J Oxidative Med Cellular Longevity"},{"key":"2417_CR52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-200161010-00005","volume":"61","author":"J Grutzendler","year":"2001","unstructured":"Grutzendler J, Morris JC (2001) Cholinesterase inhibitors for Alzheimer\u2019s disease. J Drugs 61:41\u201352","journal-title":"J Drugs"},{"key":"2417_CR53","volume":"10","author":"J Guo","year":"2020","unstructured":"Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R (2020) Memantine, donepezil, or combination therapy\u2014What is the best therapy for Alzheimer\u2019s disease? A network meta-analysis. J Brain Behavior 10:e01831","journal-title":"J Brain Behavior"},{"key":"2417_CR54","first-page":"184","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. J Sci 256:184\u2013185","journal-title":"J Sci"},{"key":"2417_CR55","first-page":"598","volume":"10","author":"X He","year":"2017","unstructured":"He X, Li Z, Rizak JD, Shihao W, Wang Z, He R, Min S, Qin D, Wang J, Xintian H (2017) Resveratrol attenuates formaldehyde induced hyperphosphorylation of tau protein and cytotoxicity in N2a cells. J Front Neurosci 10:598","journal-title":"J Front Neurosci"},{"key":"2417_CR56","volume":"29","author":"SM Hosseini","year":"2023","unstructured":"Hosseini SM, Mohammadnejad J, Salamat S, Beiram Zadeh Z, Tanhaei M, Ramakrishna S (2023) Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review. J Mater Today Chem 29:101400","journal-title":"J Mater Today Chem"},{"key":"2417_CR57","unstructured":"Identifier:, ClinicalTrials.gov. 'Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer\u00b4s Disease. '."},{"key":"2417_CR58","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030341","volume":"17","author":"W Inthachat","year":"2024","unstructured":"Inthachat W, Chantong B, Pitchakarn P, Takoon C, Karinchai J, Suttisansanee U, Temviriyanukul P (2024) Enhancing therapeutic efficacy of Donepezil, an Alzheimer\u2019s disease drug, by Diplazium esculentum (Retz.) Sw. and its phytochemicals. Pharmaceuticals (Basel) 17:341","journal-title":"Pharmaceuticals (Basel)"},{"key":"2417_CR59","volume":"2022","author":"F Islam","year":"2022","unstructured":"Islam F, Khadija JF, Harun-Or-Rashid M, Rahaman MS, Nafady MH, Islam MR, Akter A, Emran TB, Wilairatana P, Mubarak MS (2022a) Bioactive compounds and their derivatives: an insight into prospective phytotherapeutic approach against Alzheimer\u2019s disease. Oxid Med Cell Longev 2022:5100904","journal-title":"Oxid Med Cell Longev"},{"key":"2417_CR60","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1007\/s12035-022-02859-7","volume":"59","author":"F Islam","year":"2022","unstructured":"Islam F, Nafady MH, Islam MR, Saha S, Rashid S, Akter A, Harun-Or-Rashid M, Akhtar MF, Perveen A, Ashraf GM (2022) Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer\u2019s disease from bench to bedside. J Molecular Neurobiol 59:4384\u2013404","journal-title":"J Molecular Neurobiol"},{"key":"2417_CR61","volume":"12","author":"R Jadhav","year":"2023","unstructured":"Jadhav R, Kulkarni YA (2023) The combination of baicalein and memantine reduces oxidative stress and protects against \u03b2-amyloid-induced Alzheimer\u2019s disease in rat model. Antioxidants (Basel) 12:707","journal-title":"Antioxidants (Basel)"},{"key":"2417_CR62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1049\/nbt2.12127","volume":"17","author":"C Jalili","year":"2023","unstructured":"Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S, Kakebaraei S (2023) Brain targeting based nanocarriers loaded with resveratrol in Alzheimer\u2019s disease: a review. IET Nanobiotechnol 17:154\u2013170","journal-title":"IET Nanobiotechnol"},{"key":"2417_CR63","volume":"14","author":"DPW Jayatunga","year":"2022","unstructured":"Jayatunga DPW, Eugene Hone WMAD, Fernando B, Garg ML, Verdile G, Martins RN (2022) A synergistic combination of DHA, luteolin, and urolithin A against Alzheimer\u2019s disease. J Front Aging Neurosci 14:780602","journal-title":"J Front Aging Neurosci"},{"key":"2417_CR64","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/nu9101122","volume":"9","author":"Y Jia","year":"2017","unstructured":"Jia Y, Wang N, Liu X (2017) Resveratrol and amyloid-beta: mechanistic insights. J Nutrients 9:1122","journal-title":"J Nutrients"},{"key":"2417_CR65","doi-asserted-by":"crossref","first-page":"10631","DOI":"10.3390\/ijms262110631","volume":"26","author":"B Jimenez","year":"2025","unstructured":"Jimenez B, Maria T, Rivas-Garc\u00eda L, S\u00e1nchez-Gonz\u00e1lez C, Grosso G, Lipari V, Vera-Ram\u00edrez L, Battino M, Giampieri F, Quiles JL, Tamara Y (2025) Natural products in Alzheimer\u2019s disease: A systematic review of clinical trials and underlying molecular mechanisms. J Int J Molecular Sci Forbes-Hern\u00e1ndez 26:10631","journal-title":"J Int J Molecular Sci Forbes-Hern\u00e1ndez"},{"key":"2417_CR66","volume":"2","author":"OO John","year":"2022","unstructured":"John OO, Amarachi IS, Chinazom AP, Adaeze E, Kale MB, Umare MD, Upaganlawar AB (2022) Phytotherapy: A promising approach for the treatment of Alzheimer\u2019s disease. J Pharmacol Res-Modern Chinese Med 2:100030","journal-title":"J Pharmacol Res-Modern Chinese Med"},{"key":"2417_CR67","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. J Archives Toxicol 97:2499\u20132574","journal-title":"J Archives Toxicol"},{"key":"2417_CR68","unstructured":"Lopes J (2019) Combination of 2 dietary compounds may have benefits for Alzheimer\u2019s patients, mouse study suggests, Bio News. https:\/\/alzheimersnewstoday.com\/news\/combining-2-dietary-compounds-potential-benefits-alzheimers\/."},{"key":"2417_CR69","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nano.2013.01.001","volume":"9","author":"RP Joshi","year":"2013","unstructured":"Joshi RP, Negi G, Kumar A, Pawar YB, Munjal B, Bansal AK, Sharma SS (2013) SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. J Nanomed Nanotechnol Biol Med 9:776\u2013785","journal-title":"J Nanomed Nanotechnol Biol Med"},{"key":"2417_CR70","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.2174\/1381612825666191011102444","volume":"25","author":"MT Kabir","year":"2019","unstructured":"Kabir MT, Sufian MA, Uddin MS, Begum MM, Akhter S, Islam A, Mathew B, Islam MS, Amran MS, Ashraf GM (2019) NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer\u2019s therapy. Curr Pharm des 25:3506\u20133518","journal-title":"Curr Pharm des"},{"key":"2417_CR71","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.biopha.2018.03.007","volume":"101","author":"H Khan","year":"2018","unstructured":"Khan H, Amin S, Kamal MA, Patel S (2018) Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects. J Biomed Pharmacother 101:860\u2013870","journal-title":"J Biomed Pharmacother"},{"key":"2417_CR72","doi-asserted-by":"crossref","DOI":"10.2174\/97898150366641210201","volume":"12","author":"MA Khan","year":"2021","unstructured":"Khan MA, Srivastava V, Kabir M, Samal M, Insaf A, Ibrahim M, Zahiruddin S, Ahmad S (2021) Development of synergy-based combination for learning and memory using in vitro, in vivo and TLC-MS-bioautographic studies. J Front Pharmacol 12:678611","journal-title":"J Front Pharmacol"},{"key":"2417_CR73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement Transl Res Clin Interv 4:575\u2013590","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"2417_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2017.15.1.1","volume":"15","author":"S Kocahan","year":"2017","unstructured":"Kocahan S, Do\u011fan Z (2017) Mechanisms of Alzheimer\u2019s disease pathogenesis and prevention: the brain, neural pathology N-Methyl-D-Aspartate receptors, Tau protein and other risk factors. J Clinical Psychopharmacol Neurosci 15:1","journal-title":"J Clinical Psychopharmacol Neurosci"},{"key":"2417_CR75","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1038\/srep08075","volume":"5","author":"M Kodali","year":"2015","unstructured":"Kodali M, Parihar VK, Hattiangady B, Mishra V, Shuai B, Shetty AK (2015) Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature and reduced glial activation. J Sci Rep 5:8075","journal-title":"J Sci Rep"},{"key":"2417_CR76","doi-asserted-by":"crossref","DOI":"10.3390\/ph18081117","volume":"18","author":"M Kruk-S\u0142omka","year":"2025","unstructured":"Kruk-S\u0142omka M, Kuce\u0142 D, Ma\u0142ysz M, Machnikowska A, Orzelska-G\u00f3rka J, Bia\u0142a G (2025) New approaches to the treatment of Alzheimer\u2019s disease. Pharmaceuticals (Basel) 18:1117","journal-title":"Pharmaceuticals (Basel)"},{"key":"2417_CR77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. J Pharmacol Rep 67:195\u2013203","journal-title":"J Pharmacol Rep"},{"key":"2417_CR78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainresbull.2011.03.010","volume":"85","author":"A Kumar","year":"2011","unstructured":"Kumar A, Prakash A, Pahwa D (2011) Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat. J Brain Res Bull 85:158\u2013168","journal-title":"J Brain Res Bull"},{"key":"2417_CR79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2016.10.024","volume":"515","author":"P Kumar","year":"2016","unstructured":"Kumar P, Sharma G, Kumar R, Singh B, Malik R, Katare OP, Raza K (2016) Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences. J Int J Pharmaceutics 515:307\u2013314","journal-title":"J Int J Pharmaceutics"},{"key":"2417_CR80","unstructured":"Kumar A, Sidhu J, Lui F, Tsao JW (2024) Alzheimer disease. In StatPearls [internet] (StatPearls Publishing)."},{"key":"2417_CR81","doi-asserted-by":"crossref","unstructured":"Lai G, Wu H, Yang K, Hu K, Zhao W, Chen X, Li J, Wang H, Lv Z, Xie G, Wu X (2025) Potential applications of natural components of traditional Chinese medicine delivery via nanoparticle drug delivery systems in the treatment of Alzheimer\u2019s disease. J Int Nanomed 7781\u2013810.","DOI":"10.2147\/IJN.S525960"},{"key":"2417_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt155","volume":"5","author":"B Lam","year":"2013","unstructured":"Lam B, Masellis M, Freedman M, Stuss DT, Black SE (2013) Clinical, imaging, and pathological heterogeneity of the Alzheimer\u2019s disease syndrome. J Alzheimer\u2019s Res Therapy 5:1","journal-title":"J Alzheimer's Res Therapy"},{"key":"2417_CR83","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fnins.2019.00472","volume":"13","author":"D-D Li","year":"2019","unstructured":"Li D-D, Zhang Y-H, Zhang W, Zhao P (2019) Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease. J Front Neurosci 13:472","journal-title":"J Front Neurosci"},{"key":"2417_CR84","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/cells11121925","volume":"11","author":"T Li","year":"2022","unstructured":"Li T, Li L, Pember E, Li X, Zhang B, Zhu Z (2022) New insights into neuroinflammation involved in pathogenic mechanism of Alzheimer\u2019s disease and its potential for therapeutic intervention. J Cells 11:1925","journal-title":"J Cells"},{"key":"2417_CR85","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.3390\/molecules27227971","volume":"27","author":"Y Liao","year":"2022","unstructured":"Liao Y, Mai X, Xiaqing W, Xing H, Luo X, Zhang G (2022) Exploring the inhibition of quercetin on acetylcholinesterase by multispectroscopic and in silico approaches and evaluation of its neuroprotective effects on PC12 cells. J Molecules 27:7971","journal-title":"J Molecules"},{"key":"2417_CR86","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.15419\/s00m4g68","volume":"12","author":"I Long","year":"2025","unstructured":"Long I (2025) Unravelling Alzheimer\u2019s Disease: Therapeutic Strategies Aimed at neuroinflammation signalling pathway. J Biomed Res Therapy 12:7878\u20137893","journal-title":"J Biomed Res Therapy"},{"key":"2417_CR87","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/molecules22020277","volume":"22","author":"JA Loureiro","year":"2017","unstructured":"Loureiro JA, Andrade S, Duarte A, Neves AR, Queiroz JF, Nunes C, Sevin E, Fenart L, Gosselet F, Coelho MAN (2017) Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease. J Molecules 22:277","journal-title":"J Molecules"},{"key":"2417_CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2009.03.021","volume":"375","author":"X Lu","year":"2009","unstructured":"Lu X, Ji C, Huae X, Li X, Ding H, Ye M, Zhu Z, Ding D, Jiang X, Ding X (2009) Resveratrol-loaded polymeric micelles protect cells from A\u03b2-induced oxidative stress. J Int Pharmaceutics 375:89\u201396","journal-title":"J Int Pharmaceutics"},{"key":"2417_CR89","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/ptr.8192","volume":"38","author":"D Madhubala","year":"2024","unstructured":"Madhubala D, Patra A, Khan MR, Mukherjee AK (2024) Phytomedicine for neurodegenerative diseases: The road ahead. J Phytotherapy Res 38:2993\u20133019","journal-title":"J Phytotherapy Res"},{"key":"2417_CR90","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acschemneuro.8b00510","volume":"10","author":"S Malvajerd","year":"2018","unstructured":"Malvajerd S, Soroor AA, Izadi Z, Kurd M, Dara T, Dibaei M, Zadeh MS, Javar HA, Hamidi M (2018) Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: Preparation, optimization, and pharmacokinetic evaluation. J ACS Chem Neurosci 10:728\u2013739","journal-title":"J ACS Chem Neurosci"},{"key":"2417_CR91","doi-asserted-by":"crossref","first-page":"e32616","DOI":"10.1371\/journal.pone.0032616","volume":"7","author":"A Mathew","year":"2012","unstructured":"Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Venugopal K, Kumar DS (2012) Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. J PLoS one 7:e32616","journal-title":"J PLoS one"},{"key":"2417_CR92","doi-asserted-by":"crossref","unstructured":"Mohapatra S, Panda B (2026) Phytochemicals as neurotherapeutics in Alzheimer\u2019s disease: Exploring plant-based interventions for emerging complex brain disorders, J Brain Heart 025430065.","DOI":"10.36922\/BH025430065"},{"key":"2417_CR93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/08923973.2024.2444956","volume":"47","author":"Z Montazeri-Khosh","year":"2025","unstructured":"Montazeri-Khosh Z, Ebrahimpour A, Keshavarz M, Sheybani-Arani M, Samiei A (2025) Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury. J Immunopharmacol Immunotoxicol 47:159\u2013175","journal-title":"J Immunopharmacol Immunotoxicol"},{"key":"2417_CR94","first-page":"179","volume":"51","author":"EM Mostafa","year":"2025","unstructured":"Mostafa EM, Beltagy DM, Ali TM, Izzularab BM (2025) Beneficial Therapeutic Impact of Berberine and Donepezil on Neurotoxicity in Rats. J Delta J Sci 51:179\u2013197","journal-title":"J Delta J Sci"},{"key":"2417_CR95","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14656566.2022.2042514","volume":"23","author":"T Nagata","year":"2022","unstructured":"Nagata T, Shinagawa S, Nakajima S, Noda Y, Mimura M (2022) Pharmacotherapeutic combinations for the treatment of Alzheimer\u2019s disease. J Expert Opinion Pharmacotherapy 23:727\u2013737","journal-title":"J Expert Opinion Pharmacotherapy"},{"key":"2417_CR96","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/ijms20112761","volume":"20","author":"T Nakagawa","year":"2019","unstructured":"Nakagawa T, Ohta K (2019) Quercetin regulates the integrated stress response to improve memory. J Int J Molecular Sci 20:2761","journal-title":"J Int J Molecular Sci"},{"key":"2417_CR97","doi-asserted-by":"crossref","unstructured":"Ogunsuyi OB, Oluokun OO, Ademiluyi AO, Oboh G, Akeeb RA, Umar HI, Olagoke OC (2025) Synergistic effects of curcumin-donepezil therapy in a Drosophila Alzheimer\u2019s disease model, J Neurodegenerative Disease Manag 1\u201315.","DOI":"10.1080\/17582024.2025.2558428"},{"key":"2417_CR98","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","volume":"28","author":"OA Olajide","year":"2020","unstructured":"Olajide OA, Sarker SD (2020) Alzheimer\u2019s disease: natural products as inhibitors of neuroinflammation. Inflammopharmacology 28:1439\u20131455","journal-title":"Inflammopharmacology"},{"key":"2417_CR99","first-page":"178","volume":"12","author":"TA Olasehinde","year":"2024","unstructured":"Olasehinde TA, Olaokun OO (2024) The beneficial role of apigenin against cognitive and neurobehavioural dysfunction: A systematic review of preclinical investigations. J Biomed 12:178","journal-title":"J Biomed"},{"key":"2417_CR100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exger.2015.09.016","volume":"72","author":"H Ota","year":"2015","unstructured":"Ota H, Ogawa S, Ouchi Y, Akishita M (2015) Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: a possible role of nNOS and combined effects with donepezil. Exp Gerontol 72:109\u2013116","journal-title":"Exp Gerontol"},{"key":"2417_CR101","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.pharep.2016.12.002","volume":"69","author":"S Palle","year":"2017","unstructured":"Palle S, Neerati P (2017) Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases. Pharmacol Rep 69:365\u2013370","journal-title":"Pharmacol Rep"},{"key":"2417_CR102","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1021\/acschemneuro.1c00206","volume":"12","author":"SN Pandey","year":"2021","unstructured":"Pandey SN, Rangra NK, Singh S, Arora S, Gupta V (2021) Evolving role of natural products from traditional medicinal herbs in the treatment of Alzheimer\u2019s disease. J ACS Chem Neurosci 12:2718\u20132728","journal-title":"J ACS Chem Neurosci"},{"key":"2417_CR103","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","volume":"14","author":"T Pardo-Moreno","year":"2022","unstructured":"Pardo-Moreno T, Gonz\u00e1lez-Acedo A, Rivas-Dom\u00ednguez A, Garc\u00eda-Morales V, Garc\u00eda-Cozar FJ, Ramos-Rodr\u00edguez JJ, Melguizo-Rodr\u00edguez L (2022) Therapeutic approach to Alzheimer\u2019s disease: current treatments and new perspectives. J Pharmaceutics 14:1117","journal-title":"J Pharmaceutics"},{"key":"2417_CR104","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E (2022) Alzheimer\u2019s disease: treatment strategies and their limitations. J Int J Molecular Sci 23:13954","journal-title":"J Int J Molecular Sci"},{"key":"2417_CR105","doi-asserted-by":"crossref","unstructured":"Pathan AJ (2023) Limitations of Alzheimer\u2019s disease medications. J NeuroPharmac 11\u201317.","DOI":"10.37881\/1.832"},{"key":"2417_CR106","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/molecules24122287","volume":"24","author":"P-C Paula","year":"2019","unstructured":"Paula P-C, Maria S-G, Luis C-H, Patricia C-G (2019) Preventive effect of quercetin in a triple transgenic Alzheimer\u2019s disease mice model. J Molecules Gloria 24:2287","journal-title":"J Molecules Gloria"},{"key":"2417_CR107","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","volume":"89","author":"NY Pong","year":"2015","unstructured":"Pong NY, Or TCT, Ip NY (2015) Plant alkaloids as drug leads for Alzheimer\u2019s disease. J Neurochem Int 89:260\u2013270","journal-title":"J Neurochem Int"},{"key":"2417_CR108","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/ADR-200228","volume":"4","author":"S Pradeep","year":"2020","unstructured":"Pradeep S, Jain AS, Dharmashekara C, Prasad SK, Kollur SP, Syed A, Shivamallu C (2020) Alzheimer\u2019s disease and herbal combination therapy: A comprehensive review. J Alzheimer\u2019s Disease Rep 4:417\u2013429","journal-title":"J Alzheimer's Disease Rep"},{"key":"2417_CR109","doi-asserted-by":"crossref","DOI":"10.3390\/nu17152557","volume":"17","author":"N Puranik","year":"2025","unstructured":"Puranik N, Kumari M, Tiwari S, Dhakal T, Song M (2025) Resveratrol as a therapeutic agent in Alzheimer\u2019s disease: evidence from clinical studies. Nutrients 17:2557","journal-title":"Nutrients"},{"key":"2417_CR110","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/psyg.12944","volume":"23","author":"A Rahman","year":"2023","unstructured":"Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Masud AA, Saif\u2010Ur\u2010Rahman KM (2023) Aducanumab for the treatment of Alzheimer\u2019s disease: a systematic review. Psychogeriatrics 23:512\u2013522","journal-title":"Psychogeriatrics"},{"key":"2417_CR111","volume-title":"Recent frontiers of phytochemicals","author":"MS Rajput","year":"2023","unstructured":"Rajput MS, Nirmal NP, Patel V, Sarkar PD, Raval M (2023) Phytoconstituents-based nanoformulations for neurodegenerative disorders. Recent frontiers of phytochemicals. Elsevier"},{"key":"2417_CR112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2010-101374","volume":"23","author":"B Ray","year":"2011","unstructured":"Ray B, Bisht S, Maitra A, Maitra A, Lahiri DK (2011) Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc\u2122) in the neuronal cell culture and animal model: implications for Alzheimer\u2019s disease. J Alzheimers Dis 23:61\u201377","journal-title":"J Alzheimers Dis"},{"key":"2417_CR113","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","volume":"9","author":"MA Rogawski","year":"2003","unstructured":"Rogawski MA, Wenk GL (2003) The neuropharmacological basis for the use of memantine in the treatment of Alzheimer\u2019s disease. CNS Drug Rev 9:275\u2013308","journal-title":"CNS Drug Rev"},{"key":"2417_CR114","volume":"11","author":"JM Romero-M\u00e1rquez","year":"2022","unstructured":"Romero-M\u00e1rquez JM, Navarro-Hortal MD, Jim\u00e9nez-Trigo V, Mu\u00f1oz-Ollero P, Forbes-Hern\u00e1ndez TY, Esteban-Mu\u00f1oz A, Giampieri F, Delgado Noya I, Bull\u00f3n P, Vera-Ram\u00edrez L (2022) An olive-derived extract 20% rich in hydroxytyrosol prevents \u03b2-amyloid aggregation and oxidative stress, two features of Alzheimer disease, via SKN-1\/NRF2 and HSP-16.2 in Caenorhabditis elegans. Antioxidants (Basel) 11:629","journal-title":"Antioxidants (Basel)"},{"key":"2417_CR115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2014.11.014","volume":"747","author":"AK Sachdeva","year":"2015","unstructured":"Sachdeva AK, Misra S, Kaur IP, Chopra K (2015) Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence. Eur J Pharmacol 747:132\u2013140","journal-title":"Eur J Pharmacol"},{"key":"2417_CR116","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-190083","volume":"69","author":"S Sadegh Malvajerd","year":"2019","unstructured":"Sadegh Malvajerd S, Izadi Z, Azadi A, Kurd M, Derakhshankhah H, Sharifzadeh M, Akbari Javar H, Hamidi M (2019) Neuroprotective potential of curcumin-loaded nanostructured lipid carrier in an animal model of Alzheimer\u2019s disease: behavioral and biochemical evidence. J Alzheimers Dis 69:671\u2013686","journal-title":"J Alzheimers Dis"},{"key":"2417_CR117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1872208316666220302115901","volume":"16","author":"M Saeedi","year":"2022","unstructured":"Saeedi M, Mehranfar F (2022) Challenges and approaches of drugs such as memantine, donepezil, rivastigmine, and aducanumab in the treatment, control and management of Alzheimer\u2019s disease. Recent Pat Biotechnol 16:102\u2013121","journal-title":"Recent Pat Biotechnol"},{"key":"2417_CR118","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, Rainone V, Nemni R, Mancuso R, Clerici M (2016) The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. J Molecular Neurodegeneration 11:23","journal-title":"J Molecular Neurodegeneration"},{"key":"2417_CR119","doi-asserted-by":"crossref","first-page":"1004121","DOI":"10.37349\/ent.2025.1004121","volume":"5","author":"P Sarup","year":"2025","unstructured":"Sarup P, Malik J, Pahuja S (2025) A comprehensive insight into baicalein and baicalin: neuroprotective perspectives in Alzheimer\u2019s disease. J Explor Neuroprot Therapy 5:1004121","journal-title":"J Explor Neuroprot Therapy"},{"key":"2417_CR120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/00023210-200418130-00001","volume":"18","author":"B Schmitt","year":"2004","unstructured":"Schmitt B, Bernhardt T, Moeller H-J, Heuser I, Fr\u00f6lich L (2004) Combination therapy in Alzheimer\u2019s disease: a review of current evidence. J CNS Drugs 18:827\u2013844","journal-title":"J CNS Drugs"},{"key":"2417_CR121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2023.102363","volume":"134","author":"S Shao","year":"2023","unstructured":"Shao S, Ye X, Wenwen S, Wang Y (2023) Curcumin alleviates Alzheimer\u2019s disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway. J Chem Neuroanatomy 134:102363","journal-title":"J Chem Neuroanatomy"},{"key":"2417_CR122","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/jpm12091515","volume":"12","author":"J Sharifi-Rad","year":"2022","unstructured":"Sharifi-Rad J, Rapposelli S, Sestito S, Herrera-Bravo J, Arancibia-Diaz A, Salazar LA, Yeskaliyeva B, Beyatli A, Leyva-G\u00f3mez G, Gonz\u00e1lez-Contreras C (2022) Multi-target mechanisms of phytochemicals in Alzheimer\u2019s disease: effects on oxidative stress, neuroinflammation and protein aggregation. J Personal Med 12:1515","journal-title":"J Personal Med"},{"key":"2417_CR123","doi-asserted-by":"crossref","unstructured":"Sharma H, Chandra P (2024) Challenges and future prospects: A benefaction of phytoconstituents on molecular targets pertaining to Alzheimer's disease, J Int Pharmaceutical Investig 14.","DOI":"10.5530\/ijpi.14.1.15"},{"key":"2417_CR124","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11064-018-2683-8","volume":"44","author":"AA Shati","year":"2019","unstructured":"Shati AA, Alfaifi MY (2019) Trans-resveratrol inhibits tau phosphorylation in the brains of control and cadmium chloride-treated rats by activating PP2A and PI3K\/Akt induced-inhibition of GSK3\u03b2. J Neurochem Res 44:357\u2013373","journal-title":"J Neurochem Res"},{"key":"2417_CR125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4062\/biomolther.2017.189","volume":"26","author":"CY Shin","year":"2018","unstructured":"Shin CY, Kim H-S, Cha K-H, Won DH, Lee J-Y, Jang SW, Sohn UD (2018) The effects of donepezil, an acetylcholinesterase inhibitor, on impaired learning and memory in rodents. Biomol Ther 26:274","journal-title":"Biomol Ther"},{"key":"2417_CR126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02652048.2018.1441916","volume":"35","author":"M Singh","year":"2018","unstructured":"Singh M, Thakur V, Deshmukh R, Amit Sharma MS, Rathore AK, Mishra N (2018) Development and characterization of morin hydrate-loaded micellar nanocarriers for the effective management of Alzheimer\u2019s disease. J Microencapsul 35:137\u2013148","journal-title":"J Microencapsul"},{"key":"2417_CR127","doi-asserted-by":"publisher","unstructured":"Singh K, Sethi P, Jain D, Gupta JK, Waqar Z, Singh B, Syed R, Tabish M, Sharma MC (2026) Molecular mechanisms of neurodegeneration: A focus on cholinergic dysfunction and the therapeutic potential of rivastigmine derivatives. J Current Topics Med Chem. https:\/\/doi.org\/10.2174\/0115680266380856251204044937","DOI":"10.2174\/0115680266380856251204044937"},{"key":"2417_CR128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2010.01.012","volume":"389","author":"A Smith","year":"2010","unstructured":"Smith A, Giunta B, Bickford PC, Fountain M, Tan J, Shytle RD (2010) Nanolipidic particles improve the bioavailability and \u03b1-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease. J Int Pharmaceutics 389:207\u201312","journal-title":"J Int Pharmaceutics"},{"key":"2417_CR129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2018.10.012","volume":"841","author":"R SoukhakLari","year":"2018","unstructured":"SoukhakLari R, Moezi L, Pirsalami F, Ashjazadeh N, Moosavi M (2018) Curcumin ameliorates scopolamine-induced mice memory retrieval deficit and restores hippocampal p-Akt and p-GSK-3\u03b2. Eur J Pharmacol 841:28\u201332","journal-title":"Eur J Pharmacol"},{"key":"2417_CR130","volume-title":"Neuropsychopharmacotherapy","author":"GR Sridhar","year":"2021","unstructured":"Sridhar GR (2021) Acetylcholinesterase inhibitors (galantamine, rivastigmine, and donepezil). Neuropsychopharmacotherapy. Springer"},{"key":"2417_CR131","doi-asserted-by":"crossref","first-page":"9272","DOI":"10.3390\/ijms24119272","volume":"24","author":"M Su","year":"2023","unstructured":"Su M, Nizamutdinov D, Liu H, Huang JH (2023) Recent mechanisms of neurodegeneration and photobiomodulation in the context of Alzheimer\u2019s disease. Int J Molecular Sci 24:9272","journal-title":"Int J Molecular Sci"},{"key":"2417_CR132","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1007\/s11356-017-9789-4","volume":"25","author":"N Suganthy","year":"2018","unstructured":"Suganthy N, Ramkumar VS, Pugazhendhi A, Benelli G, Archunan G (2018) Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. J Environ Sci Pollution Res 25:10418\u201310433","journal-title":"J Environ Sci Pollution Res"},{"key":"2417_CR133","first-page":"1019","volume":"12","author":"MA Sultana","year":"2023","unstructured":"Sultana MA, Hia RA, Akinsiku O, Hegde V (2023) Peripheral mitochondrial dysfunction: A potential contributor to the development of metabolic disorders and Alzheimer\u2019s disease. J Biol 12:1019","journal-title":"J Biol"},{"key":"2417_CR134","first-page":"1983780","volume":"2019","author":"S Sun","year":"2019","unstructured":"Sun S, Wang Y, Ailing W, Ding Z, Liu X (2019) Influence factors of the pharmacokinetics of herbal resourced compounds in clinical practice. J Evidence-Based Complement Alternative Med 2019:1983780","journal-title":"J Evidence-Based Complement Alternative Med"},{"key":"2417_CR135","volume":"129","author":"C Sun","year":"2024","unstructured":"Sun C, Dong S, Chen W, Li J, Luo E, Ji J (2024) Berberine alleviates Alzheimer\u2019s disease by regulating the gut microenvironment, restoring the gut barrier and brain-gut axis balance. J Phytomed 129:155624","journal-title":"J Phytomed"},{"key":"2417_CR136","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-510X(00)00467-6","volume":"182","author":"CI Sze","year":"2001","unstructured":"Sze CI, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ (2001) N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer\u2019s disease. J Neurol Sci 182:151\u201359","journal-title":"J Neurol Sci"},{"key":"2417_CR137","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1016\/j.bmcl.2007.04.015","volume":"17","author":"H Tang","year":"2007","unstructured":"Tang H, Ning F-X, Wei Y-B, Huang S-L, Huang Z-S, Chan A-C, Lian-Quan G (2007) Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors. J Bioorganic Med Chem Lett 17:3765\u20133768","journal-title":"J Bioorganic Med Chem Lett"},{"key":"2417_CR138","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-021-00448-1","volume":"16","author":"T Terada","year":"2021","unstructured":"Terada T, Therriault J, Peter MS, Kang MS, Pascoal TA, Lussier F, Tissot C, Wang Y-T, Benedet A, Matsudaira T (2021) Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer\u2019s disease. J Molecular Neurodegeneration 16:28","journal-title":"J Molecular Neurodegeneration"},{"key":"2417_CR139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnagi.2018.00003","volume":"10","author":"D Tewari","year":"2018","unstructured":"Tewari D, Stankiewicz AM, Mocan A, Sah AN, Tzvetkov NT, Huminiecki L, Horba\u0144czuk JO, Atanasov AG (2018) Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs. J Front Aging Neurosci 10:3","journal-title":"J Front Aging Neurosci"},{"key":"2417_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH (2023) Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. J Inflammation 46:1\u201317","journal-title":"J Inflammation"},{"key":"2417_CR141","doi-asserted-by":"crossref","first-page":"1701921","DOI":"10.1002\/smll.201701921","volume":"13","author":"Y-H Tsou","year":"2017","unstructured":"Tsou Y-H, Zhang X-Q, Zhu H, Syed S, Xu X (2017) Drug delivery to the brain across the blood\u2013brain barrier using nanomaterials. J Small 13:1701921","journal-title":"J Small"},{"key":"2417_CR142","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM (2019) \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. J Molecular Neurodegen 14:23","journal-title":"J Molecular Neurodegen"},{"key":"2417_CR143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40199-018-0221-5","volume":"26","author":"MA Vakilinezhad","year":"2018","unstructured":"Vakilinezhad MA, Amini A, Akbari Javar H, Baha\u2019addini Beigi Zarandi BF, Montaseri H, Dinarvand R. (2018) Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer\u2019s disease animal model by reducing Tau hyperphosphorylation. J DARU J Pharmaceutical Sci 26:165\u201377","journal-title":"J DARU J Pharmaceutical Sci"},{"key":"2417_CR144","doi-asserted-by":"crossref","first-page":"566","DOI":"10.25259\/JNRP_356_2023","volume":"14","author":"A Varadharajan","year":"2023","unstructured":"Varadharajan A, Davis AD, Ghosh A, Jagtap T, Xavier A, Menon AJ, Roy D, Gandhi S, Gregor T (2023) Guidelines for pharmacotherapy in Alzheimer\u2019s disease\u2013A primer on FDA-approved drugs. J Neurosci Rural Practice 14:566","journal-title":"J Neurosci Rural Practice"},{"key":"2417_CR145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104691","volume":"86","author":"S Veysanoglu","year":"2023","unstructured":"Veysanoglu S, Ertas B, Guler E, Topal F, Ozcan GS, Duruksu G, Ece B, Cam CS, Aydemir O, Cam ME (2023) In vitro and in vivo evaluation of multi-target-directed Rivastigmine\/Memantine\/Gingko biloba-loaded nanofibers against Alzheimer\u2019s disease. J Drug Delivery Sci Technol 86:104691","journal-title":"J Drug Delivery Sci Technol"},{"key":"2417_CR146","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2174\/0115680266296001240327090111","volume":"24","author":"S Vishwas","year":"2024","unstructured":"Vishwas S, Bashir B, Birla D, Khandale N, Motamarri Venkata NL, Chaitanya DK, Chellappan GG, Negi P, Dua K, Singh SK (2024) Neuroprotective role of phytoconstituents-based nanoemulsion for the treatment of Alzheimer\u2019s disease. J Current Topics Med Chem 24:1683\u20131698","journal-title":"J Current Topics Med Chem"},{"key":"2417_CR147","doi-asserted-by":"crossref","first-page":"1296091","DOI":"10.3389\/fonc.2024.1296091","volume":"14","author":"I Waheed","year":"2024","unstructured":"Waheed I, Ali A, Tabassum H, Khatoon N, Lai W-F, Zhou X (2024) Lipid-based nanoparticles as drug delivery carriers for cancer therapy. J Front Oncol 14:1296091","journal-title":"J Front Oncol"},{"key":"2417_CR148","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 57:1041\u201348","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2417_CR149","doi-asserted-by":"crossref","first-page":"1279046","DOI":"10.3389\/fncel.2023.1279046","volume":"17","author":"H Wang","year":"2023","unstructured":"Wang H, Sun M, Li W, Liu X, Zhu M, Qin H (2023) Biomarkers associated with the pathogenesis of Alzheimer\u2019s disease. J Front Cellular Neurosci 17:1279046","journal-title":"J Front Cellular Neurosci"},{"key":"2417_CR150","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/acs.bioconjchem.4c00414","volume":"35","author":"J Wang","year":"2024","unstructured":"Wang J, Jia R, Wan W, Han H, Wang G, Li Z, Li J (2024) Drug delivery targeting neuroinflammation to treat brain diseases. J Bioconjugate Chem 35:1687\u20131698","journal-title":"J Bioconjugate Chem"},{"key":"2417_CR151","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/alz.12901","volume":"19","author":"A Wimo","year":"2023","unstructured":"Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, Guerchet M, J\u00f6nsson L, Malaha AK, Nichols E (2023) The worldwide costs of dementia in 2019. J Alzheimer\u2019s Dementia 19:2865\u20132873","journal-title":"J Alzheimer's Dementia"},{"key":"2417_CR152","doi-asserted-by":"crossref","first-page":"1161850","DOI":"10.3389\/fphar.2023.1161850","volume":"14","author":"M Wong-Guerra","year":"2023","unstructured":"Wong-Guerra M, Calfio C, Maccioni RB, Rojo LE (2023) Revisiting the neuroinflammation hypothesis in Alzheimer\u2019s disease: A focus on the druggability of current targets. J Front Pharmacol 14:1161850","journal-title":"J Front Pharmacol"},{"key":"2417_CR153","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2174\/1570159X20666211217163540","volume":"20","author":"CK Woon","year":"2022","unstructured":"Woon CK, Hui WK, Abas R, Haron MH, Das S, Lin TS (2022) Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer\u2019s disease. J Current Neuropharmacol 20:1498\u20131518","journal-title":"J Current Neuropharmacol"},{"key":"2417_CR154","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/j.bmc.2017.02.048","volume":"25","author":"J Yan","year":"2017","unstructured":"Yan J, Jinhui H, Liu A, He L, Li X, Wei H (2017) Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer\u2019s disease based on the fusion of donepezil and curcumin. J Bioorganic Med Chem 25:2946\u20132955","journal-title":"J Bioorganic Med Chem"},{"key":"2417_CR155","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/jbm.a.36493","volume":"106","author":"L Yang","year":"2018","unstructured":"Yang L, Wang W, Chen J, Wang N, Zheng G (2018) A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid \u03b2 aggregation and reactive oxygen species formation properties. J Biomed Mater Res Part A 106:3034\u20133041","journal-title":"J Biomed Mater Res Part A"},{"key":"2417_CR156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.01.055","volume":"226","author":"L Yao","year":"2016","unstructured":"Yao L, Xiao G, Song Q, Wang X, Huang M, Meng H, Hou L, Kang T, Chen J, Chen H (2016) Nanoformulated alpha-mangostin ameliorates Alzheimer\u2019s disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance. J Controlled Release 226:1\u201314","journal-title":"J Controlled Release"},{"key":"2417_CR157","first-page":"663","volume":"45","author":"BC Yarns","year":"2022","unstructured":"Yarns BC, Holiday KA, Carlson DM, Cosgrove CK, Rebecca J (2022) Pathophysiology of Alzheimer\u2019s disease. J Psychiatric Clinics Melrose 45:663\u2013676","journal-title":"J Psychiatric Clinics Melrose"},{"key":"2417_CR158","doi-asserted-by":"crossref","unstructured":"Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M (2019) Curcumin-loaded nanoparticles: A novel therapeutic strategy in treatment of central nervous system disorders. J Int J Nanomed 4449\u201360.","DOI":"10.2147\/IJN.S208332"},{"key":"2417_CR159","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12906-019-2510-z","volume":"19","author":"N-N Yuan","year":"2019","unstructured":"Yuan N-N, Cai C-Z, Ming-Yue W, Huan-Xing S, Li M, Jia-Hong L (2019) Neuroprotective effects of berberine in animal models of Alzheimer\u2019s disease: a systematic review of pre-clinical studies. J BMC Complement Alternative Med 19:109","journal-title":"J BMC Complement Alternative Med"},{"key":"2417_CR160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13020-025-01204-z","volume":"20","author":"M Yuan","year":"2025","unstructured":"Yuan M, Nguyen TTT, Gibb AJ, Xian Y-F, Hong-Xi X (2025) Potential of phytochemicals in the treatment of Alzheimer disease by modulating lysosomal dysfunction: a systematic review. J Chinese Med 20:138","journal-title":"J Chinese Med"},{"key":"2417_CR161","volume":"166","author":"MA Zandieh","year":"2023","unstructured":"Zandieh MA, Farahani MH, Daryab M, Motahari A, Gholami S, Salmani F, Karimi F, Samaei SS, Rezaee A, Rahmanian P (2023) Stimuli-responsive (nano) architectures for phytochemical delivery in cancer therapy. J Biomed Pharmacotherapy 166:115283","journal-title":"J Biomed Pharmacotherapy"},{"key":"2417_CR162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lfs.2019.03.055","volume":"224","author":"E Zaplatic","year":"2019","unstructured":"Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K (2019) Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease. J Life Sci 224:109\u2013119","journal-title":"J Life Sci"},{"key":"2417_CR163","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2014.01.041","volume":"339","author":"J Zhang","year":"2014","unstructured":"Zhang J, Li Y, Jing X, Yang Z (2014) The role of N-methyl-D-aspartate receptor in Alzheimer\u2019s disease. J Neurol Sci 339:123\u2013129","journal-title":"J Neurol Sci"},{"key":"2417_CR164","volume":"21","author":"X-W Zhang","year":"2020","unstructured":"Zhang X-W, Chen J-Y, Ouyang D, Lu J-H (2020) Quercetin in animal models of Alzheimer\u2019s disease: a systematic review of preclinical studies. Int J Mol Sci 21:493","journal-title":"Int J Mol Sci"},{"key":"2417_CR165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcis.2022.02.124","volume":"617","author":"W Zhang","year":"2022","unstructured":"Zhang W, Kandel N, Zhou Y, Smith N, Ferreira BCLB, Perez M, Claure ML, Mintz KJ, Wang C, Leblanc RM (2022) Drug delivery of memantine with carbon dots for Alzheimer\u2019s disease: blood\u2013brain barrier penetration and inhibition of tau aggregation. J Colloid Interf Sci 617:20\u201331","journal-title":"J Colloid Interf Sci"},{"key":"2417_CR166","volume":"135","author":"L-X Zhao","year":"2024","unstructured":"Zhao L-X, Ren H, Jing-Yang S, Zhang Q, He D-L, Ting-Yao W, Zhang Y-H, Wang Z-Y, Fan Y-G (2024a) Osmundacetone ameliorates Alzheimer\u2019s-like pathologies by inhibiting \u03b2-amyloid fibrillation, oxidative damage and neuroinflammation in APP\/PS1 transgenic mice. J Phytomedicine 135:156091","journal-title":"J Phytomedicine"},{"key":"2417_CR167","volume":"173","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Yan J, Huang L, Yang X (2024b) Phytochemicals targeting Alzheimer\u2019s disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action. J Biomed Pharmacotherapy 173:116373","journal-title":"J Biomed Pharmacotherapy"},{"key":"2417_CR168","first-page":"609","volume":"4","author":"CW Zhu","year":"2018","unstructured":"Zhu CW, Grossman H, Neugroschl J, Parker S, Burden A, Luo X, Sano M (2018) A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer\u2019s disease: a pilot study. Alzheimers Dement TRCI 4:609\u2013616","journal-title":"Alzheimers Dement TRCI"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02417-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:16:07Z","timestamp":1792041367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02417-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":168,"alternative-id":["2417"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02417-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The figures were created using\n                      \n                      , and the paraphrasing and grammatical corrections were assisted using QuillBot software and\n                      \n                      . The authors thoroughly reviewed, verified, and revised all AI-assisted content to ensure accuracy and originality. The authors take full responsibility for the integrity and final content of the published article.","order":4,"name":"Ethics","label":"AI disclosure statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}